P&G Adds Merck's Brands, Expands Consumer Health Categories, Footprint

P&G’s planned purchase of Merck KGaA’s consumer health care business will grow its personal health portfolio 50%, expand its OTC drug and supplement business abroad and open up new categories. CEO David Taylor framed the acquisition as another step in the firm's ongoing portfolio shakeup.

Procter & Gamble Co. is taking a sharp turn from trimming its product portfolio and streamlining its operations with an agreement to acquire Merck KGAA's dietary supplement and OTC drug lines, a move that will increase the size of P&G's consumer health business by 50%.

The planned €3.4bn ($4

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from International

More from Geography